Skye Bioscience (NASDAQ:SKYE) is set to give its latest quarterly earnings report on Tuesday, 2026-03-10. Here's what investors need to know before the announcement.
Analysts estimate that Skye Bioscience will report an earnings per share (EPS) of $-0.30.
Investors in Skye Bioscience are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings Track Record
The company's EPS missed by $0.00 in the last quarter, leading to a 2.82% increase in the share price on the following day.
Here's a look at Skye Bioscience's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.32 | -0.29 | -0.28 |
| EPS Actual | -0.32 | -0.44 | -0.28 | -0.24 |
| Price Change % | 2.82 | -0.85 | 1.12 | 19.05 |
Skye Bioscience Share Price Analysis
Shares of Skye Bioscience were trading at $0.7204 as of March 06. Over the last 52-week period, shares are down 73.25%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Skye Bioscience visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment